Showing results (151-160 of 165) with videos related to
Sort By:
Pageof 17
Frontiers in Oncology|September 9, 2020
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in LondonBeth Russell, Charlotte Moss, Sophie Papa, et al.Nature Genetics|September 4, 2023
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolutionAlba Rodriguez-Meira, Ruggiero Norfo, Sean Wen, et al.British Journal of Cancer|August 17, 2021
Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in LondonBeth Russell, Charlotte L Moss, Vallari Shah, et al.Biorxiv : the Preprint Server for Biology|July 10, 2023
Genomic and ecological factors shaping specialism and generalism across an entire subphylumDana A Opulente, Abigail Leavitt LaBella, Marie-Claire Harrison, et al.Science (New York, N.Y.)|April 25, 2024
Genomic factors shape carbon and nitrogen metabolic niche breadth across Saccharomycotina yeastsDana A Opulente, Abigail Leavitt LaBella, Marie-Claire Harrison, et al.Leukemia|March 28, 2026
Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomesLaura Li Gagnon, Andrea Duminuco, Fabio Stagno, et al.Blood|August 8, 2024
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosisAyalew Tefferi, Giovanni Barosi, Francesco Passamonti, et al.Haematologica|August 6, 2013
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studiesRuben A Mesa, Jean-Jacques Kiladjian, Srdan Verstovsek, et al.Nature Genetics|June 9, 2025
Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1ACharlotte K Brierley, Bon Ham Yip, Giulia Orlando, et al.Nature Communications|April 8, 2015
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasmsWilliam Tapper, Amy V Jones, Robert Kralovics, et al.Pageof 17